BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 25692837)

  • 1. [Renal denervation in patients with resistant hypertension: is it still possible to resuscitate?].
    Táborský M; Schejbalová M
    Vnitr Lek; 2014 Dec; 60(12):1081-5. PubMed ID: 25692837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal denervation for resistant hypertension: yes.
    Boschetti E; Alrashdi Y; Schillaci G
    Intern Emerg Med; 2016 Jun; 11(4):491-3. PubMed ID: 26970989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation.
    Olsen LK; Kamper AL; Svendsen JH; Feldt-Rasmussen B
    Eur J Intern Med; 2015 Mar; 26(2):95-105. PubMed ID: 25676808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
    Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials.
    Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
    Blood Press; 2014 Jun; 23(3):135-7. PubMed ID: 24842262
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistant Hypertension and Renal Nerve Denervation.
    Denker MG; Cohen DL
    Methodist Debakey Cardiovasc J; 2015; 11(4):240-4. PubMed ID: 27057294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
    Schlaich MP
    Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status of Renal Denervation in Hypertension.
    Briasoulis A; Bakris GL
    Curr Cardiol Rep; 2016 Nov; 18(11):107. PubMed ID: 27614466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients.
    Hayek SS; Abdou MH; Demoss BD; Legaspi JM; Veledar E; Deka A; Krishnan SK; Wilmot KA; Patel AD; Kumar VR; Devireddy CM
    Am J Hypertens; 2013 Dec; 26(12):1452-8. PubMed ID: 23934709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein M; de Marchena E
    J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation in resistant hypertension: a review of clinical trials and future perspectives.
    Yamamoto E; Sueta D; Tsujita K
    Cardiovasc Interv Ther; 2022 Jul; 37(3):450-457. PubMed ID: 35474179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
    Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal denervation in the antihypertensive arsenal - knowns and known unknowns.
    Messerli FH; Bavishi C; Brguljan J; Burnier M; Dobner S; Elijovich F; Ferdinand KC; Kjeldsen S; Laffer CL; S Ram CV; Rexhaj E; Ruilope LM; Shalaeva EV; Siontis GCM; Staessen JA; Textor SC; Vongpatanasin W; Vogt L; Volpe M; Wang J; Williams B
    J Hypertens; 2022 Oct; 40(10):1859-1875. PubMed ID: 36052518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation.
    VonAchen P; Hamann J; Houghland T; Lesser JR; Wang Y; Caye D; Rosenthal K; Garberich RF; Daniels M; Schwartz RS
    Cardiovasc Revasc Med; 2016; 17(7):470-473. PubMed ID: 27493150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal denervation in treatment-resistant hypertension: a reappraisal.
    Persu A; Jin Y; Fadl Elmula FE; Renkin J; Høieggen A; Kjeldsen SE; Staessen JA
    Curr Opin Pharmacol; 2015 Apr; 21():48-52. PubMed ID: 25601357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation for resistant hypertension: no.
    Taddei S; Dal Canto E; Bruno RM
    Intern Emerg Med; 2016 Jun; 11(4):495-8. PubMed ID: 27001888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response and non-response to renal denervation: who is the ideal candidate?
    Ukena C; Cremers B; Ewen S; Böhm M; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R54-7. PubMed ID: 23732156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.